SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b) (c),
and (d) and AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)1
Regeneration Technologies, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
75886N 10 0
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2003
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check appropriate box to designate the rule pursuant to which this Schedule is
filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
--------
1 The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
--------- ------------------------------ ---------------------------------------
CUSIP NO. 75886N 10 0 Page 2 of 5 Pages
----------- - -
-------- ------------------------------- ---------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE
PERSON (ENTITIES ONLY)
Neil Gagnon
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A
GROUP*
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
581,426
NUMBER OF -------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 344,080
EACH -------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 560,376
-------------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,203,351
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
1,763,727
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.7%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Item 1(a) Name of Issuer:
Regeneration Technologies, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
11621 Research Circle
Alachua, Florida 32615
Item 2(a) Name of Person Filing:
Neil Gagnon
Item 2(b) Address of Principal Business Office or, if none, Residence:
1370 Avenue of the Americas
Suite 2002
New York, NY 10019
Item 2(c) Citizenship:
United States of America
Item 2(d) Title of Class of Securities:
Common Stock
Item 2(e) CUSIP Number:
75886N 10 0
Item 3 If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
or (c), Check Whether the Person Filing is a:
Not Applicable
Item 4 Ownership.
Item 4(a) Amount Beneficially Owned:
As of December 31, 2003, Neil Gagnon beneficially owned 1,763,727
shares of Common Stock of Regeneration Technologies, Inc., which amount includes
(i) 376,107 shares beneficially owned by Mr. Gagnon over which he has sole
voting and sole dispositive power; (ii) 20,245 shares beneficially owned by Mr.
Gagnon over which he has sole voting power and shared dispositive power; (iii)
194,700 shares beneficially owned by Lois Gagnon, Mr. Gagnon's wife, over which
he has shared voting and shared dispositive power; (iv) 1,335 shares
beneficially owed by Mr. Gagnon and Mrs. Gagnon as Joint Tenants
with Rights of Survivorship, over which he has shared voting and shared
dispositive power; (v) 77,635 shares held by the Lois E. and Neil E. Gagnon
Foundation (the "Foundation"), of which Mr. Gagnon is a trustee and over which
he has shared voting and shared dispositive power; (vi) 70,410 shares held by
the Gagnon Family Limited Partnership (the "Partnership") of which Mr. Gagnon is
a partner and over which he has shared voting and shared dispositive power;
(vii) 56,449 shares held by the Gagnon Grandchildren Trust (the "Trust") over
which Mr. Gagnon has shared dispositive but no voting power; (viii) 182,612
shares held by a hedge fund (of which Mr. Gagnon is a general partner) over
which Mr. Gagnon has sole dispositive and sole voting power; (ix) 1,657 shares
held by the Gagnon Securities LLC P/S Plan (the "Plan") (of which Mr. Gagnon is
a Trustee) over which Mr. Gagnon has sole dispositive and sole voting power; (x)
625 shares held by the Plan, over which Mr. Gagnon has shared dispositive and
sole voting power; and (xi) 781,952 shares held for certain customers of Gagnon
Securities LLC (of which Mr. Gagnon is the Managing Member and the principal
owner) over which Mr. Gagnon has shared dispositive but no voting power.
Item 4(b) Percent of Class:
6.7% beneficially owned by Mr. Gagnon. Calculation of percentage of
beneficial ownership is based on 26,359,181 shares of Issuer's Common Stock
outstanding on November 7, 2003 as reported by the Issuer in its Quarterly
Report filed on Form 10-Q for the period ended September 30, 2003.
Item 4(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 581,426
(ii) shared power to vote or to direct the vote: 344,080
(iii)sole power to dispose or to direct the disposition of: 560,376
(iv) shared power to dispose or to direct the disposition of: 1,203,351
Items 5-9 Not applicable.
Filing of this statement by the Reporting Person shall not be deemed
an admission that he beneficially owns the securities reported herein as held in
customer accounts at Gagnon Securities LLC or by the Foundation, the
Partnership, the Trust or the Plan. Mr. Gagnon expressly disclaims beneficial
ownership of all securities held in such customer accounts or by the Foundation,
the Partnership, the Trust or the Plan. No single client's interest as reported
in the customer accounts at Gagnon Securities LLC exceeds 5% of the outstanding
Common Stock.
Item 10 Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 12, 2004
--------------------------
Date
/s/ Neil Gagnon
--------------------------
Neil Gagnon